2601c paliperidone
Oryginalny tytuł ogłoszenia
Norway – Medical equipments, pharmaceuticals and personal care products – 2601c paliperidone
Ocena szansy
Skąd ta ocena?
Szansa
30 / 100
Złożoność
50 / 100
Czynniki ryzyka
The notice lacks estimated value, award criteria, and eligibility requirements. This makes it impossible to evaluate th...
All documents are in Norwegian, which may disadvantage non-Norwegian bidders.
Submission deadline in 0 days
Głęboka analiza portfolio
Wykorzystuje:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Przegląd
Moderate opportunityKluczowe fakty
- Framework procurement
- Supplies contract
- 1 lot
- Duration until Jan 2028
- Supply of the active ingredient paliperidone
- Framework agreement with the four regional health authorities in Norway
Pokaż pełne podsumowanie
This tender by Sykehusinnkjøp HF, on behalf of the four regional health authorities in Norway, seeks to establish a framework agreement for the supply of the active ingredient paliperidone. The procedure is open, and electronic submission is required. However, critical information such as estimated value, award criteria, and eligibility requirements is missing from the notice, making it difficult to assess the opportunity fully.
Ryzyka
The notice lacks estimated value, award criteria, and eligibility requirements. This makes it impossible to evaluate th...
All documents are in Norwegian, which may disadvantage non-Norwegian bidders.
Submission deadline in 0 days
Analiza może być niepełna
Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.
Kluczowe wymagania
Technical
- Open procedure
- Place of performance: Norway
Administrative
- Electronic submission required
Wymagania mogą być niepełne.
Kryteria udzielenia
Lot 1
Zamawiający
Nazwa
Lokalizacja
VADSØ, NOR
Profil zamawiającego
Identyfikator
916879067
Działalność
Health
Części (1)
LOT-0001
2601c paliperidone
Procurement of the active ingredient paliperidone for Norwegian health authorities. The framework agreement covers supplies over approximately 15 months (planned start November 2026, end January 2028).
Lokalizacja
Czas trwania
Kategoria
Kryteria udzielenia
Termin
Szczegóły kryteriów
The contracting authority for this competition is Sykehusinnkjøp HF, on behalf of the four regional health authorities in Norway: Helse Sør-Øst RHF, Helse Vest RHF, Helse Midt-Norway RHF and Helse Nord RHF. Sykehusinnkjøp HF is procuring the active ingredient paliperidone.
Dodatkowe kody CPV
Uwaga do wartości
Pokaż oryginalne dane TED
Oryginalny opis TED
The contracting authority for this competition is Sykehusinnkjøp HF, on behalf of the four regional health authorities in Norway: Helse Sør-Øst RHF, Helse Vest RHF, Helse Midt-Norway RHF and Helse Nord RHF. Sykehusinnkjøp HF is procuring the active ingredient paliperidone.
Szczegóły zamówienia
- Data publikacji
- 24 Jun 2026
- Języki
- English, Norwegian
Metadane referencyjne
- Podstawa prawna
- 32014L0024
Identyfikatory referencyjne
- ID przetargu
- 434619-2026
Dokumenty (2)
Podobne przetargi
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Belgium – Pharmaceutical products – Antimycotica
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Ocena szansy
Skąd ta ocena?
Szansa
30 / 100
Złożoność
50 / 100
Czynniki ryzyka
The notice lacks estimated value, award criteria, and eligibility requirements. This makes it impossible to evaluate th...
All documents are in Norwegian, which may disadvantage non-Norwegian bidders.
Submission deadline in 0 days
Głęboka analiza portfolio
Wykorzystuje:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications